Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the increased (a) risk and (b) effect of covid-19 on people living with blood cancer.

Blood cancer patients have a higher chance of severe disease if they contract COVID-19 compared to other cancers, which is why they were placed on the extremely clinically vulnerable list and were advised to shield. During the height of the COVID-19 pandemic, some treatments were delayed when the risk of contracting coronavirus was higher than the risk of delaying treatment.